8-K/AShareholder Matters

ABBOTT LABORATORIES 8-K/A Report, Shareholder Vote Results (Jun 16, 2011)

Filed June 16, 2011For Securities:ABT

Summary

This 8-K/A filing from Abbott Laboratories (ABT) on June 16, 2011, serves as an amendment to a previous 8-K filed on May 5, 2011. The core purpose of this amendment is to provide an update on a specific governance matter discussed at the company's Annual Meeting of Shareholders held on April 29, 2011. Investors should note that this filing clarifies the Board of Directors' decision regarding future shareholder votes on executive compensation. The key takeaway for investors is Abbott's commitment to holding an annual advisory vote on the compensation of its named executive officers. This decision aligns with the recommendations of the Board and the results of the vote at the shareholder meeting. This move towards a 'say-on-pay' vote is a significant governance development and reflects increased shareholder engagement on executive compensation practices.

Key Highlights

  • 1Abbott Laboratories filed an 8-K/A (Amendment No. 1) on June 16, 2011.
  • 2The filing amends a previous 8-K report filed on May 5, 2011.
  • 3The amendment relates to the Annual Meeting of Shareholders held on April 29, 2011.
  • 4The Board of Directors has determined to hold an annual advisory vote on the compensation of named executive officers.
  • 5This decision was made in accordance with the Board's recommendation and based on shareholder vote results.
  • 6The company is implementing a 'say-on-pay' policy where shareholders will have an annual opportunity to vote on executive compensation.
  • 7Thomas C. Freyman, Executive Vice President, Finance and Chief Financial Officer, signed the filing.

Frequently Asked Questions

The main purpose of this 8-K/A filing is to amend a prior 8-K report and clarify Abbott Laboratories' decision to implement an annual advisory vote on the compensation of its named executive officers, following the results of their shareholder meeting.

An advisory vote on compensation, often called 'say-on-pay,' means that shareholders will have a non-binding vote to express their opinion on the company's executive compensation policies and practices. While not directly binding, these votes are taken seriously by the board and management.

The decision for Abbott Laboratories to hold annual advisory votes on executive compensation was determined by the Board of Directors based on the results of the vote at the Annual Meeting of Shareholders held on April 29, 2011.

No, this specific 8-K/A filing is solely focused on a corporate governance matter: the implementation of an annual advisory shareholder vote on executive compensation. It does not contain information on financial performance, new products, or other operational updates.